BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 11452249)

  • 21. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the IGF-I/IGFBP-3 complex on GH and ghrelin nocturnal concentrations in low birth weight children.
    Iñiguez G; Salazar T; Roman R; Avila A; Gunn RD; Cassorla F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):687-92. PubMed ID: 17054474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH;
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
    Sevigny JJ; Ryan JM; van Dyck CH; Peng Y; Lines CR; Nessly ML;
    Neurology; 2008 Nov; 71(21):1702-8. PubMed ID: 19015485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
    Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
    Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor-I (IGF-I) screening for the diagnosis of growth hormone (GH) deficiency.
    Sriphrapradang A; Mahachoklertwattana P; Choubtum L; Preeyasombat C
    J Med Assoc Thai; 1997 Jan; 80(1):51-5. PubMed ID: 9078817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN; Ginsberg JP; Hendell CD; Moshang T
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males.
    Fisker S; Nørrelund H; Juul A; Skakkebaek NE; Christiansen JS; Jørgensen JO
    Growth Horm IGF Res; 2001 Apr; 11(2):104-9. PubMed ID: 11472076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects.
    Kanaley JA; Frystyk J; Møller N; Dall R; Chen JW; Nielsen SC; Christiansen JS; Jørgensen JO; Flyvbjerg A
    Growth Horm IGF Res; 2005 Aug; 15(4):283-90. PubMed ID: 16027018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) for evaluation of children with short stature.
    Jaruratanasirikul S; Leethanaporn K; Sriplung H
    J Med Assoc Thai; 2000 Jun; 83(6):619-26. PubMed ID: 10932487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal growth despite GH, IGF-I and IGF-II deficiency.
    Hathout EH; Baylink DJ; Mohan S
    Growth Horm IGF Res; 1999 Aug; 9(4):272-7. PubMed ID: 10512693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease.
    Obermayr RP; Mayerhofer L; Knechtelsdorfer M; Mersich N; Huber ER; Geyer G; Tragl KH
    Exp Gerontol; 2005 Mar; 40(3):157-63. PubMed ID: 15763392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels.
    Schmid C; Bianda T; Zwimpfer C; Zapf J; Wiesli P
    Growth Horm IGF Res; 2005 Aug; 15(4):300-3. PubMed ID: 16054413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
    Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment.
    Zimmermann-Belsing T; Juul A; Juul Holst J; Feldt-Rasmussen U
    Growth Horm IGF Res; 2004 Jun; 14(3):235-44. PubMed ID: 15125885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ; Gravholt CH; Fisker S; Svenstrup B; Bennett P; Veldhuis J; Andersen M; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM; Sun XJ; Shao P
    Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.